Search
Research
Advances in Automated Insulin Delivery with the Medtronic 780G: The Australian ExperienceTo assess the real-world performance of MiniMed™ 780G for Australians with type 1 diabetes (T1D) following advanced hybrid closed loop (AHCL) activation and to evaluate the effect of changing from MiniMed 670/770G to 780G.
Research
A Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension versus Standard Pump TherapyA clinical trial-based economic evaluation was performed in which the net costs and effectiveness of the two treatment modalities were calculated and...